Limited Cheese Intake Paradigm Replaces Patterns of Behavioral Disorders in Experimental PTSD: Focus on Resveratrol Supplementation
Authors:
- Vadim E. TseilikmanVTVadim E. Tseilikman
- Vladislav A. ShatilovVSVladislav A. Shatilov
- Maxim S. ZhukovMZMaxim S. Zhukov
- Irina A. BukshaIBIrina A. Buksha
- Alexandr E. EpitashvilyAEAlexandr E. Epitashvily
- Ilya A. LipatovILIlya A. Lipatov
- Maxim R. AristovMAMaxim R. Aristov
- Alexandr G. KoshelevAKAlexandr G. Koshelev
- Marina N. KarpenkoMKMarina N. Karpenko
- Dmitrii S. TraktirovDTDmitrii S. Traktirov
- Viktoriya A. MaistrenkoVMViktoriya A. Maistrenko
- Mustapha KamelMKMustapha Kamel
Open Access
- 20 September 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (18) , 14343
Abstract
Currently, the efficacy of drug therapy for post-traumatic stress disorder or PTSD leaves much to be desired, making nutraceutical support a promising avenue for treatment. Recent research has identified the protective effects of resveratrol in PTSD. Here, we tested the behavioral and neurobiological effects of combining cheese consumption with resveratrol supplements in an experimental PTSD model. Using the elevated plus maze test, we observed that cheese intake resulted in a shift from anxiety-like behavior to depressive behavior, evident in increased freezing acts. However, no significant changes in the anxiety index value were observed. Interestingly, supplementation with cheese and resveratrol only led to the elimination of freezing behavior in half of the PTSD rats. We further segregated the rats into two groups based on freezing behavior: Freezing+ and Freezing0 phenotypes. Resveratrol ameliorated the abnormalities in Monoamine Oxidize -A and Brain-Derived Neurotrophic Factor gene expression in the hippocampus, but only in the Freezing0 rats. Moreover, a negative correlation was found between the number of freezing acts and the levels of Monoamine Oxidize-A and Brain-Derived Neurotrophic Factor mRNAs in the hippocampus. The study results show promise for resveratrol supplementation in PTSD treatment. Further research is warranted to better understand the underlying mechanisms and optimize the potential benefits of resveratrol supplementation for PTSD.Keywords
Funding Information
- Russian Scientific Foundation, Regional grant, Chelyabinsk Region (#23-15-20040)
This publication has 55 references indexed in Scilit:
- Predator Exposure/Psychosocial Stress Animal Model of Post-Traumatic Stress Disorder Modulates Neurotransmitters in the Rat Hippocampus and Prefrontal CortexPLOS ONE, 2014
- Traumatic stress in rats induces noradrenergic-dependent long-term behavioral sensitization: role of individual differences and similarities with dependence on drugs of abusePsychopharmacology, 2013
- Epigenetic Risk Factors in PTSD and DepressionFrontiers in Psychiatry, 2013
- Factors Influencing Biogenic Amines Accumulation in Dairy ProductsFrontiers in Microbiology, 2012
- Medical Comorbidity of Full and Partial Posttraumatic Stress Disorder in US AdultsPsychosomatic Medicine, 2011
- Hypertension in Relation to Posttraumatic Stress Disorder and Depression in the US National Comorbidity SurveyBehavioral Medicine, 2009
- Monoamine Oxidase AssaysCurrent Protocols in Toxicology, 2006
- The Contribution of an Animal Model Toward Uncovering Biological Risk Factors for PTSDAnnals of the New York Academy of Sciences, 2006
- Critical Prenatal and Postnatal Periods for Persistent Effects of Dexamethasone on Serotonergic and Dopaminergic SystemsNeuropsychopharmacology, 2005
- Diet-hormone interactions: Protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and cortisol and their respective binding globulins in manLife Sciences, 1987